SEVEN EIGHT CAPITAL, LP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 203 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,194,111
-7.2%
57,299
+6.7%
0.14%
-34.3%
Q2 2023$1,286,690
+191.8%
53,724
+99.5%
0.21%
+142.0%
Q3 2022$441,000
+66.4%
26,935
+146.6%
0.09%
+151.4%
Q1 2022$265,000
+22.1%
10,923
+107.7%
0.04%
-25.5%
Q3 2020$217,000
-55.1%
5,258
-47.3%
0.05%
-86.7%
Q2 2020$483,000
-87.9%
9,968
-89.3%
0.35%
+67.3%
Q4 2019$3,983,000
-19.5%
93,099
-32.3%
0.21%
-19.2%
Q3 2019$4,948,000
+555.4%
137,469
+386.7%
0.26%
+552.5%
Q2 2019$755,000
+254.5%
28,244
+255.5%
0.04%
+263.6%
Q1 2019$213,000
-84.0%
7,944
-77.6%
0.01%
-93.3%
Q3 2017$1,334,000
+13240.0%
35,403
+11941.8%
0.16%
+8050.0%
Q1 2017$10,000
-96.9%
294
-97.3%
0.00%
-96.9%
Q4 2016$320,000
-37.6%
11,094
-23.0%
0.06%
-81.7%
Q4 2015$513,000
+288.6%
14,400
+260.0%
0.35%
+203.5%
Q3 2015$132,000
-62.2%
4,000
-63.6%
0.12%
-80.2%
Q4 2014$349,00011,0000.58%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders